Skip to main content
Premium Trial:

Request an Annual Quote

MICROARRAYS: EU Group Uses Gene Arrays to Hunt for GMOs


A seven-lab consortium funded by the European Commission has commandeered the microarray for a new application: spotting GMOs. Particularly in the EU, where food has to be labeled as GMO or non-GMO, testing foods for GMOs could become a major market.

José Remacle, a leader of the project, says the group has been developing low-density microarrays to test for specific sequences of seven known GMOs, and that these chips should be ready for validation testing by September. “We have developed a full technology platform for the chips,” he says, adding that his lab in Belgium spun off Advanced Array Technology to commercialize various microarrays.

The decision to use arrays was an obvious one, Remacle says. “You have to make a lot of detections simultaneously,” he says. “For that, [the microarray] is the perfect tool.”

Validation testing poses some problems. “Once you process the food, you cut down the DNA. … This is the biggest problem for GMO detection,” Remacle says. “So we really have to validate the tool. In the first round we will do only food which has not been cooked or microwaved.” Several national labs will thoroughly test the chips, which will then be produced and sold to the food industry or official laboratories responsible for food control, Remacle says.

The labs making up the GMOchip project are Laboratoire de Biochimie Cellulaire in Belgium; Unité de Phyto-pathologie et Méthodologie de la Détection in France; Bras-series Kronenbourg in France; Laboratory of the Government Chemist in UK; La Concurrence, La Consommation, ET La Repression des Fraudes in France; Consejo Superior de Investigaciones Cientificas in Spain; and Agency BATS in Switzerland.

— Meredith Salisbury


The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.